Copyright
©The Author(s) 2019.
World J Meta-Anal. Mar 31, 2019; 7(3): 110-119
Published online Mar 31, 2019. doi: 10.13105/wjma.v7.i3.110
Published online Mar 31, 2019. doi: 10.13105/wjma.v7.i3.110
Ref. | Country | No. of patientsSimethicone/placebo | Bowel preparation used | Simethicone | Timing of Simethicone | Timing of bowel preparation | Diet prior to colonoscopy |
McNally et al[19] | United States | 49/48 | 6L PEG | 160 mg | Mixed with PEG | Not clear | NA |
Shaver et al[18] | United States | 102/102 | 5L PEG | 75 mL (30% simethicone) | 45 mL before and 30 mL after ingestion of PEG | Night before | NA |
Lazzaroni et al[13] | Italy | 57/48 | 4L PEG | 120 mg | Mixed with PEG | Split dose | NA |
Sudduth et al[17] | United States | 42/44 | 45 mL NaP × 2 doses | 320 mg | 160 mg after each dose of 45 mL NaP | Split dose | Clear liquid the day before |
Altintas et al[14] | Turkey | 82/83 | 90 mL NaP/133 mL NaP | 300 mg | Capsule containing simethicone given 3 times/d × 5 d | Split dose | Watery or low fiber diet × 5 d |
Tongprasert et al[12] | Thailand | 62/60 | 45 mL NaP × 2 doses | 480 mg | 240 mg with each 45 mL NaP | NA | Low residue the day before |
Jansen et al[16] | United States | 177/193 | 4L PEG/PEG-Asc | 200 mg (20 mL 10 mg/mL) | 20 mL with the last L of PEG | Split dose | NA |
Matro et al[15] | United States | 62/61 | PEG-Asc | 400 mg | Added to PEG | Split dose | Low residue for breakfast (the day before), followed by clear liquid |
Yoo et al[11] | South Korea | 130/130 | PEG-Asc | 400 mg | Added to the last 500 mL of clear fluid | Split dose | Low residue × 3 days/clear liquid the night before |
Zhang et al[9] | China | 289/290 | 2L PEG | 1200 mg | Added to PEG | Day of procedure | Low residue the day before |
Bai et al[10] | China | 294/289 | 2L PEG | 1200 mg (30 mL, 40 mg/mL) | Added to PEG | Day of procedure | Low residue/clear liquid the night before |
PEG purgatives | NaP purgatives | Simethicone dose above the mean (478 mg) | Simethicone dose below the mean(478 mg) | |
Inadequate bowel preparation | 0.44 (0.26-0.73), P = 0.002, n = 6 | 0.82 (0.41-1.67), P = 0.59, n = 2 | 0.61 (0.38-0.98), P = 0.04, n = 4 | 0.29 (0.07-1.18), P = 0.08, n = 4 |
Significant bubbles | 1.42 (1.2-1.7), P < 0.0001, n = 7 | 1.84 (1.1-2.9), P = 0.01, n = 2 | 1.79 (1.26-2.53), P = 0.001, n = 3 | 1.37 (1.17-1.59), P < 0.0001, n = 6 |
ADR | NA | NA | 1.08 (1.03-1.15), P = 0.003, n = 2 | 1.0 (0.85-1.19), P = 0.98, n = 2 |
- Citation: Madhoun MF, Hayat M, Ali IA. Higher dose of simethicone decreases colonic bubbles and increases prep tolerance and quality of bowel prep: Meta-analysis of randomized controlled trials. World J Meta-Anal 2019; 7(3): 110-119
- URL: https://www.wjgnet.com/2308-3840/full/v7/i3/110.htm
- DOI: https://dx.doi.org/10.13105/wjma.v7.i3.110